Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, New, 2022 Q3

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, New

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q3 2022: Stock ORCHARD THERAPEUTICS PLC; Country of operation —; Class SPON ADS; Shares before 0.
  • Q3 2022: Stock RENREN INC; Country of operation —; Class SPONSORED ADS; Shares before 0.
  • Q3 2022: Stock JIANPU TECHNOLOGY INC; Country of operation —; Class ADS COMMON; Shares before 0.
  • Q3 2022: Stock MORPHOSYS AG; Country of operation —; Class SPONSORED ADS; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2022ORCHARD THERAPEUTICS PLC
CUSIP 68570P101
—SPON ADS02,290,342+2,290,342$0$1,145+$1,1452022-11-14
Q3 2022RENREN INC
CUSIP 759892300
—SPONSORED ADS07,744+7,744$0$229+$2292022-11-14
Q3 2022JIANPU TECHNOLOGY INC
CUSIP 47738D309
—ADS COMMON077,864+77,864$0$126+$1262022-11-14
Q3 2022MORPHOSYS AG
CUSIP 617760202
—SPONSORED ADS020,049+20,049$0$101+$1012022-11-14
Q3 2022CANGO INC
CUSIP 137586103
—ADS043,150+43,150$0$99+$992022-11-14
Q3 2022TREMOR INTL LTD
CUSIP 89484T104
—ADS011,040+11,040$0$76+$762022-11-14
Q3 2022BURNING ROCK BIOTECH LTD
CUSIP 12233L107
—SPONSORED ADS026,006+26,006$0$63+$632022-11-14
Q3 2022CHEMOMAB THERAPEUTICS LTD
CUSIP 16385C104
—SPONSORED ADS021,226+21,226$0$53+$532022-11-14
Q3 202217 ED & TECHNOLOGY GROUP INC
CUSIP 81807M205
—ADS033,389+33,389$0$45+$452022-11-14
Q3 2022BIT MINING LIMITED
CUSIP 055474100
—SPON ADR REP A0151,323+151,323$0$42+$422022-11-14
Q3 2022QUOIN PHARMACEUTICALS LTD
CUSIP 74907L201
—SPONSORED ADS017,614+17,614$0$39+$392022-11-14
Q3 2022ZEPP HEALTH CORPORATION
CUSIP 98945L105
—SPONSORED ADS021,732+21,732$0$30+$302022-11-14
Q3 2022CELYAD ONCOLOGY SA
CUSIP 151205200
—ADR016,654+16,654$0$22+$222022-11-14
Q3 2022AKSO HEALTH GROUP
CUSIP 98422P108
—ADS023,209+23,209$0$21+$212022-11-14
Q3 2022AESTHETIC MED INTL HLDG GR L
CUSIP 00809M104
—ADS012,287+12,287$0$21+$212022-11-14
Q3 2022WISEKEY INTERNATIONAL HLDS L
CUSIP 97727L309
—SPON ADS010,641+10,641$0$17+$172022-11-14
Q3 2022ADVANCED HUMAN IMAGING LTD
CUSIP 00777C104
—SPON ADS029,475+29,475$0$16+$162022-11-14
Q3 2022PINTEC TECHNOLOGY HLDGS LTD
CUSIP 72352G206
—SPONSORED ADS052,738+52,738$0$14+$142022-11-14
Q3 2022AMTD IDEA GROUP
CUSIP 00180G106
—SPONSORED ADS010,825+10,825$0$13+$132022-11-14
Q3 2022AMBRX BIOPHARMA INC
CUSIP 02290A102
—SPONSORED ADS012,116+12,116$0$13+$132022-11-14
Q3 2022ADDEX THERAPEUTICS LTD
CUSIP 00654J107
—SPONSORED ADS012,803+12,803$0$10+$102022-11-14
Q3 2022BEST INC
CUSIP 08653C502
—SPONSORED ADS012,875+12,875$0$9+$92022-11-14
Q3 2022MEDIGUS LTD
CUSIP 58471G300
—SPONSORED ADS015,214+15,214$0$8+$82022-11-14